title: Mapping CushingQoL scores onto SF-6D utility values in patients with Cushing's syndrome.
abstract: OBJECTIVE
  To construct a prediction model of preference-adjusted health status (SF-6D) for Cushing's syndrome using a disease-specific health-related quality of life (HRQOL) measure (CushingQoL).
  
  
  METHODS
  Data were obtained from the original multicenter, multinational study to validate the CushingQoL questionnaire. HRQOL was measured using the CushingQoL and the SF-36 questionnaires. SF-6D scores were calculated from responses on the SF-36. Sociodemographic and clinical data were also collected. Various predictive models were tested and the final one was selected on the basis of four criteria: explanatory power, consistency of estimated coefficients, normality of prediction errors, and parsimony.
  
  
  RESULTS
  For the mapping analysis, data were available from 116 of the 125 patients included in the original validation study. Mean (SD) age was 45.3 (13.1) years and the sample was predominantly (83 %) female. Patients had a mean (SD) CushingQoL score of 52.9 (21.9), whereas the SF-6D (derived from SF-36) was skewed towards better health with a mean of 0.71 (median 0.74) on a scale of -0.704 to 1. Of the various models tested, a model which included the intercept (0.61), CushingQoL overall score, level one in CushingQoL item 2 (always have pain preventing me from leading a normal life), and level one in CushingQoL item 10 (my illness always affects my everyday activities) best met the four criteria for model selection. The model had an adjusted R (2) of 0.60 and a root mean square error of 0.084.
  
  
  CONCLUSIONS
  Although the mapping function finally selected appears to be able to accurately map CushingQoL scores onto SF-6D outcomes at the group level, further testing is required to validate the model in independent patient samples.
authors.affiliation: Health Economics and Outcomes Research, IMS Health, Barcelona, Spain. mroset@es.imshealth.com
authors.forename: Montse
authors.initials: M
authors.lastname: Roset
authors.forename: Xavier
authors.initials: X
authors.lastname: Badia
authors.forename: Anna
authors.initials: A
authors.lastname: Forsythe
authors.forename: Susan M
authors.initials: SM
authors.lastname: Webb
mesh_terms: D017281:Cost of Illness; D003480:Cushing Syndrome / Q000628:therapy*; D005060:Europe; D005260:Female; D006304:Health Status; D006801:Humans; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D057240:Patient Preference; D011594:Psychometrics; D011788:Quality of Life
references.citation: Eur J Health Econ. 2010 Apr;11(2):215-25
references.pmid: 19585162
references.citation: Eur J Endocrinol. 2008 May;158(5):623-30
references.pmid: 18426820
references.citation: Value Health. 2007 Sep-Oct;10(5):408-14
references.pmid: 17888106
references.citation: J Clin Endocrinol Metab. 2003 Dec;88(12):5593-602
references.pmid: 14671138
references.citation: Nat Rev Endocrinol. 2011 Mar 22;7(8):445-55
references.pmid: 21423244
references.citation: Ann Med. 2001 Jul;33(5):337-43
references.pmid: 11491192
references.citation: Pharmacoeconomics. 2000 Jan;17(1):13-35
references.pmid: 10747763
references.citation: Pharmacoeconomics. 1995 Jun;7(6):490-502
references.pmid: 10155335
references.citation: Ann Surg. 2007 May;245(5):790-4
references.pmid: 17457173
references.citation: J Health Econ. 2002 Mar;21(2):271-92
references.pmid: 11939242
references.citation: Lancet. 2006 May 13;367(9522):1605-17
references.pmid: 16698415
references.citation: Int J Technol Assess Health Care. 1989;5(4):559-75
references.pmid: 2634630
references.citation: Eur J Endocrinol. 2011 Sep;165(3):383-92
references.pmid: 21715416
references.citation: J Clin Endocrinol Metab. 2006 Feb;91(2):447-53
references.pmid: 16278266
references.citation: Qual Life Res. 2008 Nov;17(9):1173-81
references.pmid: 18807209
references.citation: J Rheumatol. 1995 Jun;22(6):1188-90
references.pmid: 7674253
references.citation: J Clin Epidemiol. 1998 Nov;51(11):1115-28
references.pmid: 9817129
references.citation: Med Care. 1992 Jun;30(6):473-83
references.pmid: 1593914
references.citation: Stat Med. 1998 Jul 30;17(14):1623-34
references.pmid: 9699234
references.citation: J Clin Endocrinol Metab. 2005 Jun;90(6):3279-86
references.pmid: 15741267